The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000883314p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
3/07/2026
Date registered
Help: Date registered
17/07/2026
Date last updated
Help: Date last updated
17/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
An 8-Week Intervention Comparing Two Resistance Training Methods to Enhance Activities of Daily Living and Well-being in Healthy Older Adults.
Scientific title
An 8-Week Randomised Controlled Trial Comparing Velocity-based Training and American College of Sports Medicine (ACSM) Guidelines in Enhancing Activities of Daily Living and Well-being in Healthy Older Adults
Additional trial identifiers [1] 316941 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Age-related decline in muscle function 341668 0
Age-related decline in performing Activities of Daily Living 342888 0
Condition category
Condition code
Musculoskeletal 337755 337755 0 0
Other muscular and skeletal disorders
Physical Medicine / Rehabilitation 337756 337756 0 0
Physiotherapy

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants will complete two familiarisation sessions in Week 1, with each session lasting approximately 1 hour. They will then complete three testing sessions, each lasting approximately 2–2.5 hours, at three time points: Week 2, pre-control; Week 6, pre-intervention; and Week 15, post-intervention.

During the familiarisation sessions, participants will be instructed to become familiar with the testing procedures and exercises included in the training program. These will include the Sensory Organisation Test, Repeated Chair Rise, Time Up and Go Test, 400-walk Test, leg press, chest press, lat pulldown, leg extension, seated row, and leg curl.

All participants will complete a three-week control period from Weeks 3 to 5 to establish stable baseline measures. During this period, they will be instructed to maintain their usual physical activities and avoid engaging in any form of resistance training.

Following the control period, participants assigned to the intervention group will commence a face-to-face resistance training program at the Vario Health Clinic at Edith Cowan University, Perth, Western Australia. The exercise program will run for 8 weeks, from Weeks 7 to 14, with sessions conducted twice per week. Each session will last approximately 1 hour, with a minimum of 48 hours between training sessions. All sessions will be performed using resistance training machines under strict in-person supervision by qualified instructors to ensure proper technique and minimise injury risk.

The intervention group will follow a velocity-based training (VBT) protocol, in which participants will complete repetitions until movement velocity decreases by more than 30% relative to the fastest repetition within the set. Participants will perform three sets of six exercises: chest press, leg press, lateral pulldown, seated leg curl, seated row, and leg extension. They are instructed to control the eccentric phase of each exercise and complete the concentric phase as fast as possible. Training load is autoregulated using a 30% velocity-loss threshold. If a participant completes 10 repetitions without reaching the 30% threshold, the training load will be increased; if the threshold is reached before 10 repetitions, the load will be decreased. Real-time visual and verbal velocity feedback will be provided via a tablet synced with an Enode device.

To ensure adherence, instructors will record attendance, sets, and repetitions in a training log, and provide strong verbal encouragement. Participants who miss sessions will attend make-up sessions, and only those who complete at least 80% of the prescribed sessions will be included in the final analysis.
Intervention code [1] 333880 0
Lifestyle
Intervention code [2] 334714 0
Prevention
Description of the comparator or control
The active comparator in this study will be a resistance training program based on ACSM guidelines for older adults, whereby participants will train using a 10RM load throughout the intervention. Similar to the intervention group, participants will complete two familiarisation sessions in Week 1, followed by three testing sessions at different time points: Week 2, pre-control; Week 6, pre-intervention; and Week 15, post-intervention. Participants will then complete a three-week control period from Weeks 3 to 5, during which they will maintain their habitual physical activity without undertaking resistance training. This period will be used to establish stable baseline measures. Following randomisation, participants will begin an eight-week, face-to-face training intervention at the Vario Health Clinic at Edith Cowan University, Perth, Western Australia. Training sessions will be held twice per week, with at least 48 hours between sessions, from Weeks 7 to 14. To ensure safety and proper exercise technique, all sessions will be supervised in person by qualified instructors.

Participants in the ACSM comparator group will perform the same six machine-based exercises: chest press, leg press, lateral pulldown, seated leg curl, seated row, and leg extension. The volume is consistent at three sets per exercise. While they will also be instructed to control the eccentric phase and complete the concentric phase as fast as possible, no real-time velocity feedback is provided and their load regulation differs. This group will train at a 10RM load until reaching failure. Instructor monitoring includes recording attendance and training data in a dedicated log, alongside providing strong verbal encouragement. Adherence is managed through make-up sessions for missed visits, and a minimum completion rate of 80% is required for the final analysis.
Control group
Active

Outcomes
Primary outcome [1] 345211 0
Muscle mass
Timepoint [1] 345211 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Primary outcome [2] 345212 0
Upper body strength
Timepoint [2] 345212 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Primary outcome [3] 346054 0
Lower body strength
Timepoint [3] 346054 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Secondary outcome [1] 460978 0
Perceived well-being
Timepoint [1] 460978 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Secondary outcome [2] 464459 0
Training-related adverse events and safety outcomes
Timepoint [2] 464459 0
Continuously monitored and recorded from Week 7 to Week 14 (during the 8-week training intervention period).
Secondary outcome [3] 464836 0
Balance
Timepoint [3] 464836 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Secondary outcome [4] 464837 0
Functional Mobility
Timepoint [4] 464837 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Secondary outcome [5] 464838 0
Functional Mobility
Timepoint [5] 464838 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)
Secondary outcome [6] 464839 0
Functional Mobility
Timepoint [6] 464839 0
Weeks 2 (pre-control), 6 (post-control), and 15 (post-intervention)

Eligibility
Key inclusion criteria
Individuals who are apparently healthy, aged between 60-85.
Individuals with at least 3 months of resistance training experience (to ensure exercise safety and familiarisation, and to reduce confounding learning effects on strength and neuromuscular measures).
Minimum age
60 Years
Maximum age
85 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
Individuals with uncontrolled hypertension, cognitive impairments, or musculoskeletal, cardiovascular, or neurological conditions contraindicating resistance training.
Individuals taking medications that could confound data, such as testosterone and corticosteroids.
Individuals with a body mass index (BMI) of 30 kg/m² or above (due to elevated health risks).

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is concealed using an independent, central computerised randomisation service (https://www.sealedenvelope.com/). The person determining participant eligibility will be unaware of the group allocation until the participant is registered in the system.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation. The randomisation sequence is generated using computer-generated randomly permuted blocks (via https://www.sealedenvelope.com/) and is stratified by biological sex.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Baseline demographic characteristics between the two groups will be compared using independent samples t-tests for continuous variables, including age, body mass index, baseline strength, and body composition. For categorical variables, chi-square tests of independence will determine group differences. Linear mixed-effects models will be used to analyse within-participant changes over time and between-group differences in activities of daily living, neuromuscular, and well-being outcomes. Training adherence will be summarised descriptively as the number and percentage of completed sessions. Adverse events will be summarised by number, type, severity, and relatedness to the intervention. Where appropriate, between-group differences in adherence and adverse event rates will be explored using descriptive statistics and suitable group comparison tests.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA

Funding & Sponsors
Funding source category [1] 321535 0
University
Name [1] 321535 0
Edith Cowan University
Country [1] 321535 0
Australia
Primary sponsor type
University
Name
Edith Cowan University
Address
Country
Australia
Secondary sponsor category [1] 324303 0
None
Name [1] 324303 0
Address [1] 324303 0
Country [1] 324303 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320070 0
Edith Cowan University Human Research Ethics Committee
Ethics committee address [1] 320070 0
Ethics committee country [1] 320070 0
Australia
Date submitted for ethics approval [1] 320070 0
22/05/2026
Approval date [1] 320070 0
Ethics approval number [1] 320070 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149330 0
Mr Haoxuan He
Address 149330 0
Edith Cowan University, 270 Joondalup Dr, Joondalup WA 6027
Country 149330 0
Australia
Phone 149330 0
+61 421920891
Fax 149330 0
Email 149330 0
Contact person for public queries
Name 149331 0
Haoxuan He
Address 149331 0
Edith Cowan University, 270 Joondalup Dr, Joondalup WA 6027
Country 149331 0
Australia
Phone 149331 0
+61 421920891
Fax 149331 0
Email 149331 0
Contact person for scientific queries
Name 149332 0
Haoxuan He
Address 149332 0
Edith Cowan University, 270 Joondalup Dr, Joondalup WA 6027
Country 149332 0
Australia
Phone 149332 0
+61 421920891
Fax 149332 0
Email 149332 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Due to participant privacy constraints, individual participant data will not be shared.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.